-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, a study published in the journal STROKE showed that in patients with intracranial venous thrombosis (CVT), DOAC was similar in efficacy to warfarin, but had a better safety profile
Recently, a study published in the journal STROKE showed that in patients with intracranial venous thrombosis (CVT), DOAC was similar in efficacy to warfarin, but had a better safety profile
Results of the study showed that of 1025 patients with CVT at 27 centers, 845 were included in the final analysis
Table 1.
Table 1.
Original source:
Original source:Yaghi S, Shu L, Bakradze E et al.
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study
Leave a Comment